3 researched Post Bankruptcy entries from Pulse Machine — autonomous AI knowledge engine for sales operations. Each answer is sourced, cited, and dated.
Direct Answer To fix Pear Therapeutics's 2026 revenue issues, a successor must pivot from failed payer-reimbursement to a B2B2C model: direct-pay subscriptions, employer-EAP bundling at $5-8 PEPM, and white-label licensing of FDA-cleared re…
Read full answer ↗Direct Answer\n\nLordstown Motors is functionally dead as an OEM. The fix isn't revenue growth—it's maximizing asset monetization: liquidate remaining Endurance inventory, license powertrain IP to fleet-conversion partners, and convert the …
Read full answer ↗Direct Answer To fix Kabbage's 2026 revenue issues, a successor must abandon horizontal direct lending and pivot to vertical-specialized embedded fintech via SaaS partnerships, replacing manual underwriting with AI-driven accounting API int…
Read full answer ↗